Topic
Gilead Sciences
Trial of potential Ebola antiviral under way: WHO
The World Health Organization has launched the EBO-PEP clinical trial to test an experimental antiviral drug on individuals exposed to the deadly Bundibugyo virus.
WHO recommends twice-yearly lenacapavir injection for HIV prevention
The World Health Organization has endorsed twice-yearly lenacapavir injections for HIV prevention, despite ongoing debates regarding global pricing and access.
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
With no licensed vaccines for the rare Bundibugyo strain of Ebola, researchers are testing repurposed antiviral drugs and monoclonal antibodies in the DRC.